Supernus INDV
NASDAQ INDV
$36.25 +0.88 (+2.49%)
At close: Nov 2, 2026 · 4:00 PM EST

Supernus (INDV) Return on Invested Capital [ROIC] (2023 - 2026)

Updated

Indivior Pharmaceuticals (INDV) reported Return on Invested Capital [ROIC] of 132.03% for Q3 2026, down 30.36 percentage points from 162.39% a year earlier but up 9.55 percentage points from the prior quarter.

Analysis

Supernus (INDV) Return on Invested Capital [ROIC] (2023 - 2026) Analysis & Trends

For FY2025, Indivior Pharmaceuticals posted Return on Invested Capital [ROIC] of 212.17%, up 190.55 percentage points from FY2024.

  • Return on Invested Capital [ROIC] has a three-year change of +222.50 percentage points (FY2022 to FY2025).
  • By year, Return on Invested Capital [ROIC] came in at 21.63% in FY2024 (+82.21 pp), -60.59% in FY2023 (-50.27 pp) and -10.32% in FY2022.
  • Five-year quarterly Return on Invested Capital [ROIC] spans a low of 0.00% in Q1 2025 and a high of 223.54% in Q2 2025.
  • Per Business Quant data, the three quarters before Q3 2026 came in at 122.48% (Q2 2026), 100.65% (Q1 2026) and 137.03% (Q4 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 132.03%
Jun 30, 2026 122.48%
Mar 31, 2026 100.65%
Dec 31, 2025 137.03%
Sep 30, 2025 162.39%
Jun 30, 2025 223.54%
Mar 31, 2025 0.00%
Sep 30, 2023 -742.53%
API Access

Supernus Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=INDV&period=max&api_key=YOUR_API_KEY